Literature DB >> 18604599

Differential effects of chronic antidepressant treatment on shuttle box escape deficits induced by uncontrollable stress.

Gerald Valentine1, Antonia Dow, Mounira Banasr, Brian Pittman, Ronald Duman.   

Abstract

RATIONALE: The transient behavioral deficit produced in rodents by typical learned helplessness (LH) procedures limits the utility of LH in identifying the therapeutic mechanisms associated with chronic antidepressant administration. In addition, LH procedures do not differentiate between different antidepressant classes as observed in the forced swim test.
OBJECTIVES: To produce both a long lasting and antidepressant reversible behavioral deficit in a modified LH procedure that administers inescapable shock (IS) in the same operant chamber used for shuttle box escape testing.
RESULTS: A single IS session produced a robust increase in the number of escape failures (FR-2 escape contingency) that endured for at least 21 days. This escape deficit was reversed by desipramine (24 mg/kg/day, 6 days) at the first shuttle box session. Fluoxetine (5 mg/kg/day, 6 and 21 days) improved escape performance only after repeated test sessions. In contrast, fluoxetine (5 mg/kg/day, 21 days) completely reversed the first shuttle box test escape deficit induced by exposure to a chronic unpredictable stress procedure devoid of shocks or exposure to operant chambers. These differential drug effects may be due to the presence or absence of contextual cues during escape testing. Repeated re-exposure to the IS context enhanced the FR-2 escape deficit.
CONCLUSIONS: These data suggest that performing escape testing and IS in the same environment improves the preclinical modeling of the time-dependency and behavioral pattern of antidepressant response observed clinically. Additionally, contextual information associated with the IS environment modulates escape performance and may interact differentially with discrete antidepressant classes.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18604599      PMCID: PMC2729428          DOI: 10.1007/s00213-008-1239-z

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  32 in total

1.  Behavioural and biochemical studies of citalopram and WAY 100635 in rat chronic mild stress model.

Authors:  Mariusz Papp; Irena Nalepa; Lucyna Antkiewicz-Michaluk; Connie Sánchez
Journal:  Pharmacol Biochem Behav       Date:  2002-05       Impact factor: 3.533

2.  Role of fear in mediating shuttle escape learning deficit produced by inescapable shock.

Authors:  S F Maier
Journal:  J Exp Psychol Anim Behav Process       Date:  1990-04

3.  Failure to escape traumatic shock.

Authors:  M E Seligman; S F Maier
Journal:  J Exp Psychol       Date:  1967-05

4.  Learned helplessness in the rat.

Authors:  M E Seligman; G Beagley
Journal:  J Comp Physiol Psychol       Date:  1975-02

Review 5.  Neurobiology of depression.

Authors:  Eric J Nestler; Michel Barrot; Ralph J DiLeone; Amelia J Eisch; Stephen J Gold; Lisa M Monteggia
Journal:  Neuron       Date:  2002-03-28       Impact factor: 17.173

6.  Shuttle-box deficits induced by inescapable shocks in rats: reversal by the beta-adrenoreceptor stimulants clenbuterol and salbutamol.

Authors:  P Martin; P Soubrie; P Simon
Journal:  Pharmacol Biochem Behav       Date:  1986-02       Impact factor: 3.533

7.  Reversal of helpless behavior by serotonin uptake blockers in rats.

Authors:  P Martin; P Soubrié; A J Puech
Journal:  Psychopharmacology (Berl)       Date:  1990       Impact factor: 4.530

8.  The impaired coping induced by early deprivation is reversed by chronic fluoxetine treatment in adult fischer rats.

Authors:  D Rüedi-Bettschen; J Feldon; C R Pryce
Journal:  Behav Pharmacol       Date:  2004-09       Impact factor: 2.293

9.  Antidepressant effects of citalopram and CRF receptor antagonist CP-154,526 in a rat model of depression.

Authors:  David H Overstreet; Adam Keeney; Sandra Hogg
Journal:  Eur J Pharmacol       Date:  2004-05-25       Impact factor: 4.432

10.  Onset and early behavioral effects of pharmacologically different antidepressants and placebo in depression.

Authors:  Martin M Katz; Janet L Tekell; Charles L Bowden; Steve Brannan; John P Houston; Nancy Berman; Alan Frazer
Journal:  Neuropsychopharmacology       Date:  2004-03       Impact factor: 7.853

View more
  12 in total

1.  Behaviour of a genetic mouse model of depression in the learned helplessness paradigm.

Authors:  Laure Bougarel; Jérôme Guitton; Luc Zimmer; Jean-Marie Vaugeois; Malika El Yacoubi
Journal:  Psychopharmacology (Berl)       Date:  2011-02-22       Impact factor: 4.530

2.  Wnt2 expression and signaling is increased by different classes of antidepressant treatments.

Authors:  Hideki Okamoto; Bhavya Voleti; Mounira Banasr; Maysa Sarhan; Vanja Duric; Matthew J Girgenti; Ralph J Dileone; Samuel S Newton; Ronald S Duman
Journal:  Biol Psychiatry       Date:  2010-06-08       Impact factor: 13.382

3.  Stress induces equivalent remodeling of hippocampal spine synapses in a simulated postpartum environment and in a female rat model of major depression.

Authors:  Judith Baka; Eszter Csakvari; Orsolya Huzian; Nikoletta Dobos; Laszlo Siklos; Csaba Leranth; Neil J MacLusky; Ronald S Duman; Tibor Hajszan
Journal:  Neuroscience       Date:  2016-12-22       Impact factor: 3.590

Review 4.  GLYX-13, an NMDA receptor glycine site functional partial agonist enhances cognition and produces antidepressant effects without the psychotomimetic side effects of NMDA receptor antagonists.

Authors:  Joseph R Moskal; Ronald Burch; Jeffrey S Burgdorf; Roger A Kroes; Patric K Stanton; John F Disterhoft; J David Leander
Journal:  Expert Opin Investig Drugs       Date:  2013-11-20       Impact factor: 6.206

5.  Lesions of the basolateral amygdala reverse the long-lasting interference with shuttle box escape produced by uncontrollable stress.

Authors:  Benjamin N Greenwood; Paul V Strong; Monika Fleshner
Journal:  Behav Brain Res       Date:  2010-03-10       Impact factor: 3.332

6.  Restoring mood balance in depression: ketamine reverses deficit in dopamine-dependent synaptic plasticity.

Authors:  Pauline Belujon; Anthony A Grace
Journal:  Biol Psychiatry       Date:  2014-05-06       Impact factor: 13.382

7.  Blockade of NOP receptor modulates anxiety-related behaviors in mice exposed to inescapable stress.

Authors:  Aldemara I Silva; Victor A D Holanda; Joaquim G Azevedo Neto; Edilson D Silva Junior; Vanessa P Soares-Rachetti; Girolamo Calo; Chiara Ruzza; Elaine C Gavioli
Journal:  Psychopharmacology (Berl)       Date:  2020-02-24       Impact factor: 4.530

Review 8.  Modeling postpartum depression in rats: theoretic and methodological issues.

Authors:  Ming Li; Shinn-Yi Chou
Journal:  Dongwuxue Yanjiu       Date:  2016-07-18

Review 9.  Dynorphin, stress, and depression.

Authors:  Allison T Knoll; William A Carlezon
Journal:  Brain Res       Date:  2009-09-24       Impact factor: 3.252

10.  Antidepressant activity of nociceptin/orphanin FQ receptor antagonists in the mouse learned helplessness.

Authors:  Victor A D Holanda; Iris U Medeiros; Laila Asth; Remo Guerrini; Girolamo Calo'; Elaine C Gavioli
Journal:  Psychopharmacology (Berl)       Date:  2016-04-30       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.